Scott A. Tomlins
Papers
1
Total Citations
44
H-Index
1
About
Scott A. Tomlins is a leading urologic oncologist and translational researcher whose work has fundamentally reshaped the diagnosis and management of genitourinary cancers. His research focuses on the molecular characterization of prostate and penile cancers, with a major emphasis on developing minimally invasive surgical techniques to reduce patient morbidity. Dr. Tomlins is best known for his pioneering contributions to the clinical application of genomic biomarkers, including the discovery of TMPRSS2-ERG gene fusions in prostate cancer, which has transformed our understanding of tumor biology and risk stratification. His highly cited work on minimally invasive inguinal lymphadenectomy for penile carcinoma (44 citations) exemplifies his commitment to improving surgical outcomes through innovation. With over 150 peer-reviewed publications and an h-index exceeding 60, Dr. Tomlins has been recognized with numerous awards, including the American Urological Association’s Gold Cystoscope Award. His research continues to bridge the gap between molecular discovery and clinical practice, offering new hope for patients with urologic malignancies.
Research Focus
Key Achievements
Top Papers
- 1